September 3, 2010 – Clinilabs announced today that they have been selected to conduct a Phase I/II clinical research study of an investigational vaccine for HIV.
August 24, 2010 – Clinilabs announced today that they have been selected to conduct a Phase I clinical research study of an investigational medication for Rosacea.
August 11, 2010 – Clinilabs announced today that Dr. Jon Freeman, Director of Neuroscience Research, delivered a presentation to the Division of Personalized Medicine at the United States Food and Drug Administration (FDA).
April 8, 2010 - Clinilabs announced today that it has signed a Master Services Agreement (MSA) with NewCardio, Inc. (OTC BB: NWCI), a cardiac diagnostic technology provider.
March 12, 2010 - Clinilabs is proud to be a platinum sponsor for the 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
February 2, 2010 – Clinilabs is pleased to announce the release of Clinical InSite™, a document management solution for clinical trials that significantly reduces the cost of information management, and that provides novel workflow options that cut the cost of clinical monitoring and auditing.
January 28, 2010 - Clinilabs is proud to announce that the Company has formed a collaboration with the Renal Research Institute, LLC (RRI), with headquarters in New York.
|
